التفاصيل البيبلوغرافية
| العنوان: |
Bradykinin B2 Receptor Antagonist off Label Use in Short-Term Prophylaxis in Hereditary Angioedema |
| المؤلفون: |
Angeletti, C., Angeletti, P.M., Mastrobuono, F., Pilotti, L., Ciccozzi, A., Guetti, C. |
| المصدر: |
International Journal of Immunopathology and Pharmacology ; volume 27, issue 4, page 653-659 ; ISSN 2058-7384 2058-7384 |
| بيانات النشر: |
SAGE Publications |
| سنة النشر: |
2014 |
| مصطلحات موضوعية: |
Pharmacology, Immunology, Immunology and Allergy |
| الوصف: |
Hereditary angioedema type I (HAE-C1-INH) is an inherited disorder characterized by repeated severe angioedema attacks mostly triggered by traumas, emotional stress, increased estrogen levels or surgical procedures, in particular, odontostomatological interventions. Icatibant, a bradykinin B2 receptor antagonist, has been approved for treatment of HAE attacks. In this paper we describe the “off label” administration of icatibant as short-term prophylaxis of dental extraction in a patient with HAE with the aim of preventing perioperative angioedema attacks. The drug showed an effective and safe profile. Thus, a short-term prophylaxis of angioedema attacks in patients with HAE may be arranged on a multidisciplinary basis, according to the clinical history of each single patients. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1177/039463201402700423 |
| الإتاحة: |
https://doi.org/10.1177/039463201402700423Test |
| حقوق: |
http://journals.sagepub.com/page/policies/text-and-data-mining-licenseTest |
| رقم الانضمام: |
edsbas.E45F6D5F |
| قاعدة البيانات: |
BASE |
